Serelaxin in Acute Heart Failure: Most Recent Update on Clinical and Preclinical Evidence

This article summarizes the most updated published preclinical and clinical study data on serelaxin, including pharmacokinetic, pharmacodynamic, safety studies in hepatic, renal impaired patients, phase II and phase III trials.
This article is protected by copyright. All rights reserved.

Source: Cardiovascular Therapeutics - September 30, 2016 Category: Cardiology Authors: Raktim Kumar Ghosh, Kinjal Banerjee, Ramyashree Tummala, Somedeb Ball, Keyvan Ravakhah, Anjan Gupta Tags: Commissioned Article (Review) Source Type: research